Loading...
Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
OBJECTIVES: To review published cost-effectiveness analyses (CEA) assessing bortezomib (BTZ) for multiple myeloma (MM) and explore possible bias affecting the cost-effectiveness of BTZ. METHODS: Literature was searched for published CEAs assessing BTZ or BTZ-containing regimens for MM from 2003 to 2...
Na minha lista:
| Udgivet i: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861606/ https://ncbi.nlm.nih.gov/pubmed/27217786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S104195 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|